SCHEMBL10169462

SCHEMBL10169462

Bc1ccc(OCCN2CCOCC2)cc1F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
KDM4E B2RXH2 2/20 0.60
NPC1 O15118 3/20 0.56
RAB9A P51151 2/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
LTA4H P09960 1/20 0.52
CA12 O43570 1/20 0.51
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA7 P43166 1/20 0.51
CA9 Q16790 1/20 0.51
TSHR P16473 2/20 0.50
CYP1A2 P05177 1/20 0.50
CHRM2 P08172 1/20 0.50
CHRM1 P11229 1/20 0.50
HTR2A P28223 1/20 0.50
MAPK1 P28482 1/20 0.50
SCN1A P35498 1/20 0.50
HTR2B P41595 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12260624 0.86 ESR1 (0.59) LTA4HHRH3
SCHEMBL14047042 0.84 ALDH1A1 (0.54) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL1911879 0.84 NPC1 (0.69) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL538618 0.83 ALDH1A1 (0.60) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL1962706 0.83 ALDH1A1 (0.60) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL30402431 0.83 ALDH1A1 (0.60) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL2816112 0.81 ALDH1A1 (0.58) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL20522213 0.81 KDM4E (0.60) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL2077596 0.80 KDM4E (0.56) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL14084486 0.79 NPC1 (0.66) ALDH1A1KDM4ENPC1RAB9ALTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836169-B9 COMPOSITIONS AND METHODS OF TREATING CELL PROLIFERATION DISORDERS KINEX PHARMACEUTICALS LLC (US) 2012-07-04 EP disclosed
EP-1836169-B1 COMPOSITIONS AND METHODS OF TREATING CELL PROLIFERATION DISORDERS KINEX PHARMACEUTICALS LLC (US) 2012-02-08 EP disclosed